Results 211 to 220 of about 748,540 (242)

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Filippo Miglior, Terri Lynn Shigle   +2 more
exaly  

The importance of immunization in cancer prevention, treatment, and survivorship

Ca-A Cancer Journal for Clinicians, 2017
Ted Gansler, Christopher R Flowers, Saad B Omer   +2 more
exaly  

Disparities in liver cancer occurrence in the United States by race/ethnicity and state

Ca-A Cancer Journal for Clinicians, 2017
Farhad Islami, Rebecca L Siegel, Ahmedin Jemal   +2 more
exaly  

Cancer‐related risk factors and preventive measures in US Hispanics/Latinos

Ca-A Cancer Journal for Clinicians, 2012
Priti Bandi
exaly  

Therapeutic strategies for hepatitis B virus infection: towards a cure

Nature Reviews Drug Discovery, 2019
Antonio Bertoletti, Fabien Zoulim, Jinlin Hou   +2 more
exaly  

Hepatitis C therapeutics: current status and emerging strategies

Nature Reviews Drug Discovery, 2002
Ding-wei Ye
exaly  

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

Nature, 2009
Alexander Ploss, Matthew J Evans
exaly  

Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor

Nature, 2016
Rudolf Beran, Simon P Fletcher, Michel Strubin   +2 more
exaly  

Hepatitis E and pregnancy: current state

Reviews in Medical Virology, 2017
María Teresa Pérez-gracia, Beatriz Suay-garcía   +1 more
exaly  

Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

Molecular Carcinogenesis, 2011
Chen Wu, Dongxin Lin
exaly